Yeo KR - Search Results

1

Predicting CHD risk in patients with diabetes mellitus.

Yeo WW, Yeo KR. Yeo WW, et al. Among authors: yeo kr. Diabet Med. 2001 May;18(5):341-4. doi: 10.1046/j.1464-5491.2001.00510.x. Diabet Med. 2001. PMID: 11472442 No abstract available.

2

Coronary risk versus cardiovascular risk for treatment decisions in mild hypertension.

Yeo WW, Yeo KR. Yeo WW, et al. Among authors: yeo kr. J Cardiovasc Risk. 2002 Oct;9(5):275-80. doi: 10.1177/174182670200900508. J Cardiovasc Risk. 2002. PMID: 12394321

3

Enhanced cholesterol reduction by simvastatin in diltiazem-treated patients.

Yeo KR, Yeo WW, Wallis EJ, Ramsay LE. Yeo KR, et al. Among authors: yeo ww. Br J Clin Pharmacol. 1999 Oct;48(4):610-5. doi: 10.1046/j.1365-2125.1999.00066.x. Br J Clin Pharmacol. 1999. PMID: 10583033 Free PMC article.

4

Should we treat high-normal blood pressure?

Yeo KR, Yeo WW. Yeo KR, et al. Among authors: yeo ww. J Hypertens. 2002 Oct;20(10):2057-62. doi: 10.1097/00004872-200210000-00026. J Hypertens. 2002. PMID: 12359985

5

The effect of chronic tobacco smoking on arterial stiffness.

Rehill N, Beck CR, Yeo KR, Yeo WW. Rehill N, et al. Among authors: yeo ww, yeo kr. Br J Clin Pharmacol. 2006 Jun;61(6):767-73. doi: 10.1111/j.1365-2125.2006.02630.x. Br J Clin Pharmacol. 2006. PMID: 16722843 Free PMC article.

6

Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach.

Yeo KR, Jamei M, Rostami-Hodjegan A. Yeo KR, et al. Expert Rev Clin Pharmacol. 2013 Mar;6(2):143-57. doi: 10.1586/ecp.13.4. Expert Rev Clin Pharmacol. 2013. PMID: 23473592 Review.

7

Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure.

Yeo KR, Kenny JR, Rostami-Hodjegan A. Yeo KR, et al. Eur J Clin Pharmacol. 2013 Jun;69(6):1311-20. doi: 10.1007/s00228-012-1467-3. Epub 2013 Jan 11. Eur J Clin Pharmacol. 2013. PMID: 23307233

8

Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine.

Heydari A, Yeo KR, Lennard MS, Ellis SW, Tucker GT, Rostami-Hodjegan A. Heydari A, et al. Among authors: yeo kr. Drug Metab Dispos. 2004 Nov;32(11):1213-7. doi: 10.1124/dmd.104.001180. Epub 2004 Aug 24. Drug Metab Dispos. 2004. PMID: 15328252

9

Inhibitory effects of verapamil and diltiazem on simvastatin metabolism in human liver microsomes.

Yeo KR, Yeo WW. Yeo KR, et al. Among authors: yeo ww. Br J Clin Pharmacol. 2001 May;51(5):461-70. doi: 10.1046/j.1365-2125.2001.01386.x. Br J Clin Pharmacol. 2001. PMID: 11422004 Free PMC article.

10

Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model.

Cubitt HE, Yeo KR, Howgate EM, Rostami-Hodjegan A, Barter ZE. Cubitt HE, et al. Among authors: yeo kr. Xenobiotica. 2011 Aug;41(8):623-38. doi: 10.3109/00498254.2011.560294. Epub 2011 Mar 24. Xenobiotica. 2011. PMID: 21434772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results